BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2026 6:30:55 AM | Browse: 23 | Download: 59
Publication Name World Journal of Gastroenterology
Manuscript ID 121501
Country China
Received
2026-03-26 02:03
Peer-Review Started
2026-03-26 02:04
First Decision by Editorial Office Director
2026-04-03 10:29
Return for Revision
2026-04-03 10:29
Revised
2026-04-26 18:00
Publication Fee Transferred
2026-04-30 08:51
Editorial Processing by Scientific Editor
2026-06-09 02:35
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-09 08:15
Articles in Press
2026-06-09 08:15
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-10-19 00:17
Publish the Manuscript Online
2026-10-27 06:30
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Real-world predictive model for immune checkpoint inhibitor-induced hepatitis using baseline cytotoxic T-lymphocyte counts
Manuscript Source Unsolicited Manuscript
All Author List Wen-Ting Peng, Fei-Lan Yang, Shi-Fang Peng and Lei Fu
ORCID
Author(s) ORCID Number
Wen-Ting Peng http://orcid.org/0000-0002-9072-1332
Lei Fu http://orcid.org/0000-0001-7550-1254
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China No. 82570747
Provincial Natural Science Foundation of Hunan Province No. 2022JJ30954
Provincial Natural Science Foundation of Hunan Province No. 2025JJ50599
Corresponding Author Lei Fu, PhD, Professor, Department of Infectious Diseases, Xiangya Hospital Central South University, No. 87 Xiangya Road, Changsha 410008, Hunan Province, China. fulei92@126.com
Key Words Immune checkpoint inhibitors; Liver injury; Predictive model; T cell subpopulation; Complement; Immune-mediated hepatitis
Core Tip This retrospective study of 544 cancer patients receiving immune checkpoint inhibitors identifies baseline peripheral cluster of differentiation (CD) 3+ CD8+ T cell counts as a novel independent predictor of immune-mediated hepatitis. Integrating this immune parameter with alanine transaminase and complement 4, the authors constructed a nomogram that achieved good discriminatory performance (area under the curve 0.81 in training and 0.80 in validation). This model provides a clinically accessible tool for pre-treatment risk stratification.
Publish Date 2026-10-27 06:30
Citation

Peng WT, Yang FL, Peng SF, Fu L. Real-world predictive model for immune checkpoint inhibitor-induced hepatitis using baseline cytotoxic T-lymphocyte counts. World J Gastroenterol 2026; 32(47): 121501

URL https://www.wjgnet.com/1007-9327/full/v32/i47/121501.htm
DOI https://doi.org/10.3748/wjg.121501
Full Article (PDF) WJG-32-121501-with-cover.pdf